Study of radiotherapy dose escalation with Intensity Modulated Radiation Therapy (IMRT) and synchronous Cetuximab for intermediate stage head and neck cancer.
Latest Information Update: 09 Sep 2019
At a glance
- Drugs Cetuximab (Primary)
- Indications Head and neck cancer
- Focus Adverse reactions
- Acronyms INTENSE
Most Recent Events
- 16 Aug 2011 New trial record